{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T21:40:12Z","timestamp":1737495612902,"version":"3.33.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,10,25]],"date-time":"2007-10-25T00:00:00Z","timestamp":1193270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2007,11,22]]},"DOI":"10.1007\/s00210-007-0201-7","type":"journal-article","created":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T07:25:01Z","timestamp":1193210701000},"page":"285-293","source":"Crossref","is-referenced-by-count":3,"title":["The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes"],"prefix":"10.1007","volume":"376","author":[{"given":"George R.","family":"Kracke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean P.","family":"Stoneking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua M.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon M.","family":"Tilghman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen C.","family":"Washington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine A.","family":"Hotaling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel O.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Tobias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,25]]},"reference":[{"key":"201_CR1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s002109900078","volume":"360","author":"BE Akinshola","year":"1999","unstructured":"Akinshola BE, Taylor RE, Ogunseitan AB, Onaivi ES (1999) Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 360:242\u2013248","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"201_CR2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0028-3908(02)00364-7","volume":"44","author":"KV Allen","year":"2003","unstructured":"Allen KV, McGregor IS, Hunt GE, Singh GE, Mallet PE (2003) Regional differences in naloxone modulation of \u03949-THC induced Fos expression in rat brain. Neuropharmacology 44:264\u2013274","journal-title":"Neuropharmacology"},{"key":"201_CR3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","volume":"163","author":"F Berrendero","year":"2002","unstructured":"Berrendero F, Maldonaldo R (2002) Involvement of the opioid system in the anxiolytic-like effects induced by \u03949-tetrahydrocannabinol. Psychopharmacology 163:111\u2013117","journal-title":"Psychopharmacology"},{"key":"201_CR4","first-page":"263","volume":"200","author":"AS Bloom","year":"1977","unstructured":"Bloom AS, Dewey WL, Harris LS, Brosius KK (1977) 9-nor-9\u03b2-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: comparisons with morphine. J Pharmacol Exp Ther 200:263\u2013270","journal-title":"J Pharmacol Exp Ther"},{"key":"201_CR5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-3-0348-8129-6_5","volume-title":"Mechanisms and mediators of neuropathic pain","author":"V Chapman","year":"2002","unstructured":"Chapman V, Dickenson AH (2002) Pharmacologic plasticity associated with neuropathic pain states. In: Malmberg AB, Chaplan SR (eds) Mechanisms and mediators of neuropathic pain. Birkh\u00e4user, Basel, pp 79\u201387"},{"key":"201_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1098-7339(06)80055-6","volume":"22","author":"B Coda","year":"1997","unstructured":"Coda B, Bausch S, Hass M, Chavkin C (1997) The hypothesis that antagonism of fentanyl analgesia by 2-chloroprocaine is mediated by direct action on opioid receptors. Reg Anesth 22:43\u201352","journal-title":"Reg Anesth"},{"key":"201_CR7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000112901","volume":"38","author":"P Consroe","year":"1997","unstructured":"Consroe P, Musty R, Rein J, Tillery W, Pertwee R (1997) The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 38:44\u201348","journal-title":"Eur Neurol"},{"key":"201_CR8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","volume":"78","author":"DG Demuth","year":"2006","unstructured":"Demuth DG, Molleman A (2006) Cannabinoid signalling. Life Sci 78:549\u2013563","journal-title":"Life Sci"},{"key":"201_CR9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1152\/jn.01227.2005","volume":"96","author":"A Fisyunov","year":"2006","unstructured":"Fisyunov A, Tsintsadze V, Min R, Burnashev N, Lozovaya N (2006) Cannabinoids modulate the P-type high-voltage-activated calcium currents in Purkinje neurons. J Neurophysiol 96:1267\u20131277","journal-title":"J Neurophysiol"},{"key":"201_CR10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1126\/science.1075453","volume":"297","author":"JA Gray","year":"2002","unstructured":"Gray JA, Roth BL (2002) A last GASP for GPCRs? Science 297:529\u2013531","journal-title":"Science"},{"key":"201_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(95)11289-9","volume":"186","author":"DJ Henry","year":"1995","unstructured":"Henry DJ, Chavkin C (1995) Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci Lett 186:91\u201394","journal-title":"Neurosci Lett"},{"key":"201_CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)13308-5","volume":"221","author":"U Herzberg","year":"1997","unstructured":"Herzberg U, Eliav E, Bennett GJ, Kopin IJ (1997) The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci Lett 221:157\u2013160","journal-title":"Neurosci Lett"},{"key":"201_CR13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/bja\/77.4.441","volume":"77","author":"K Hirota","year":"1996","unstructured":"Hirota K, Lambert DG (1996) Ketamine: its mechanism(s) of action and unusual clinical uses. Br J Anaesth 77:441\u2013444","journal-title":"Br J Anaesth"},{"key":"201_CR14","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1073\/pnas.0409888102","volume":"102","author":"MM Ibrahim","year":"2005","unstructured":"Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, Davar G, Makriyannis A, Vanderah TW, Mata HP, Malan TP (2005) CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA 102:3093\u20133098","journal-title":"Proc Natl Acad Sci USA"},{"key":"201_CR15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1471-4892(01)00120-5","volume":"2","author":"L Iversen","year":"2002","unstructured":"Iversen L, Chapman V (2002) Cannabinoids: a real prospect for pain relief? Curr Opin Pharmacol 2:50\u201355","journal-title":"Curr Opin Pharmacol"},{"key":"201_CR16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","volume":"372","author":"M Kathmann","year":"2006","unstructured":"Kathmann M, Flau K, Redmer A, Trankle C, Schlicker E (2006) Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 372:354\u2013361","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"201_CR17","unstructured":"Kracke GR, Stoneking SP, Ball JM, Tilghman BM, Tobias JD, Johnson JO (2006) The effect of the cannabinoids, anandamide and WIN 55,212-2, on mu opioid receptors expressed in Xenopus oocytes. International Anesthesia Research Society Annual Meeting. Abstract S\u2013211"},{"key":"201_CR18","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1046\/j.1365-2044.2001.02269.x","volume":"56","author":"RN Kumar","year":"2001","unstructured":"Kumar RN, Chambers WA, Pertwee RG (2001) Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia 56:1059\u20131068","journal-title":"Anaesthesia"},{"key":"201_CR19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(99)01756-4","volume":"839","author":"J Manzanares","year":"1999","unstructured":"Manzanares J, Corchero J, Fuentes JA (1999a) Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats. Brain Res 839:173\u2013179","journal-title":"Brain Res"},{"key":"201_CR20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","volume":"20","author":"J Manzanares","year":"1999","unstructured":"Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA (1999b) Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20:287\u2013294","journal-title":"Trends Pharmacol Sci"},{"key":"201_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-2999(99)00479-3","volume":"378","author":"DJ Mason","year":"1999","unstructured":"Mason DJ, Lowe J, Welch SP (1999) Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception. Eur J Pharmacol 378:237\u2013248","journal-title":"Eur J Pharmacol"},{"key":"201_CR22","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-3565(24)35147-X","volume":"291","author":"SD McAllister","year":"1999","unstructured":"McAllister SD, Griffen G, Satin LS, Abood ME (1999) Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a Xenopus oocyte expression system. J Pharmacol Exp Ther 291:618\u2013626","journal-title":"J Pharmacol Exp Ther"},{"key":"201_CR23","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1523\/JNEUROSCI.21-14-05344.2001","volume":"21","author":"M Navarro","year":"2001","unstructured":"Navarro M, Carrera MRA, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, Del Arco I, Villanua MA, Koob GF, Rodriguez de Fonseca F (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci 21:5344\u20135350","journal-title":"J Neurosci"},{"key":"201_CR24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00210-003-0755-y","volume":"367","author":"N Niederhoffer","year":"2003","unstructured":"Niederhoffer N, Schmid K, Szabo B (2003) The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 367:434\u2013443","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"201_CR25","first-page":"1209","volume":"260","author":"I Oye","year":"1992","unstructured":"Oye I, Paulsen O, Maurset A (1992) Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 260:1209\u20131213","journal-title":"J Pharmacol Exp Ther"},{"key":"201_CR26","first-page":"868","volume":"10","author":"CB Pert","year":"1974","unstructured":"Pert CB, Snyder SH (1974) Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol Pharmacol 10:868\u2013879","journal-title":"Mol Pharmacol"},{"key":"201_CR27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(95)00560-D","volume":"684","author":"G Pugh","year":"1995","unstructured":"Pugh G, Abood ME, Welch SP (1995) Antisense oligodeoxynucleotides to the kappa-1 receptor block the antinociceptive effects of delta 9-THC in the spinal cord. Brain Res 684:157\u2013158","journal-title":"Brain Res"},{"key":"201_CR28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00000542-198010000-00008","volume":"55","author":"AL Quasha","year":"1980","unstructured":"Quasha AL, Eger EI, Tinker JH (1980) Determination and applications of MAC. Anesthesiology 55:315\u2013334","journal-title":"Anesthesiology"},{"key":"201_CR29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/B978-0-12-185287-0.50020-X","volume-title":"Methods in neuroscience\u2014ion channels of excitable cells, vol 19","author":"MW Quick","year":"1994","unstructured":"Quick MW, Lester HA (1994) Methods of expression of excitability proteins in Xenopus oocytes. In: Narahashi T (ed) Methods in neuroscience\u2014ion channels of excitable cells, vol 19. Academic, San Diego, pp 261\u2013279"},{"key":"201_CR30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjp.0706757","volume":"148","author":"C Rios","year":"2006","unstructured":"Rios C, Gomes I, Devi LA (2006) \u03bc opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br J Pharmacol 148:387\u2013395","journal-title":"Br J Pharmacol"},{"key":"201_CR31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1523\/JNEUROSCI.21-03-00823.2001","volume":"21","author":"JJ Rodriguez","year":"2001","unstructured":"Rodriguez JJ, Mackie K, Pickel VM (2001) Ultrastructural localization of the CB1 cannabinoid receptor in \u03bc-opioid receptor patches of the rat caudate putamen nucleus. J Neurosci 21:823\u2013833","journal-title":"J Neurosci"},{"key":"201_CR32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuropharm.2006.05.019","volume":"51","author":"ANM Schoffelmeer","year":"2006","unstructured":"Schoffelmeer ANM, Hogenboom F, Wardeh G, De Vries TJ (2006) Interactions between CB1 cannabinoid and \u03bc opioid receptors mediating inhibition of neurotransmitter release in rat nucleur accumbens core. Neuropharmacology 51:773\u2013781","journal-title":"Neuropharmacology"},{"key":"201_CR33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0091-3057(97)00583-2","volume":"60","author":"FL Smith","year":"1998","unstructured":"Smith FL, Fujimori K, Welch SP (1998) Characterization of delta 9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. Pharmacol Biochem Behav 60:183\u2013191","journal-title":"Pharmacol Biochem Behav"},{"key":"201_CR34","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","volume":"276","author":"G Tanda","year":"1977","unstructured":"Tanda G, Pontieri FE, Di Chiara G (1977) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common \u03bc1 opioid receptor mechanism. Science 276:2048\u20132050","journal-title":"Science"},{"key":"201_CR35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0014-2999(94)90003-5","volume":"260","author":"SN Thorat","year":"1994","unstructured":"Thorat SN, Bhargava HN (1994) Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice. Eur J Pharmacol 260:5\u201313","journal-title":"Eur J Pharmacol"},{"key":"201_CR36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(81)90217-X","volume":"70","author":"FC Tulunay","year":"1981","unstructured":"Tulunay FC, Ayhan IH, Portoghese PS, Takemori AE (1981) Antagonism by chlornaltrexamine of some effects of delta 9-tetrahydrocannabinol in rats. Eur J Pharmacol 70:219\u2013224","journal-title":"Eur J Pharmacol"},{"key":"201_CR37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(02)01712-0","volume":"445","author":"G Vacca","year":"2002","unstructured":"Vacca G, Serra S, Brunetti G, Carai MAM, Gessa GL, Colombo G (2002) Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB1 receptor antagonist, SR 141716. Eur J Pharmacol 445:55\u201359","journal-title":"Eur J Pharmacol"},{"key":"201_CR38","first-page":"534","volume":"241","author":"PJJ Vaysse","year":"1987","unstructured":"Vaysse PJJ, Gardner EL, Zukin RS (1987) Modulation of rat brain opioid receptors by cannabinoids. J Pharmacol Exp Ther 241:534\u2013539","journal-title":"J Pharmacol Exp Ther"},{"key":"201_CR39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pbb.2005.01.021","volume":"81","author":"D Vigano","year":"2005","unstructured":"Vigano D, Rubino T, Parolaro (2005) Molecular and cellular basis of cannabinoid and opioid interactions. Pharmacol Biochem Behav 81:360\u2013368","journal-title":"Pharmacol Biochem Behav"},{"key":"201_CR40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0091-3057(01)00694-3","volume":"71","author":"CM Williams","year":"2002","unstructured":"Williams CM, Kirkham TC (2002) Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71:333\u2013340","journal-title":"Pharmacol Biochem Behav"},{"key":"201_CR41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2006.04.003","volume":"539","author":"IJ Williams","year":"2006","unstructured":"Williams IJ, Edwards S, Rubo A, Haller VL, Stevens DL, Welch SP (2006) Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by \u03949-tetrahydrocannabinol. Eur J Pharmacol 539:57\u201363","journal-title":"Eur J Pharmacol"},{"key":"201_CR42","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1021\/jm00241a012","volume":"18","author":"RS Wilson","year":"1975","unstructured":"Wilson RS, May EL (1975) Analgesic properties of the tetrahydrocannabinols, their metabolites, and analogs. J Med Chem 18:700\u2013703","journal-title":"J Med Chem"},{"key":"201_CR43","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1074\/jbc.271.19.11449","volume":"271","author":"L Zhang","year":"1996","unstructured":"Zhang L, Yu Y, Mackin S, Weight FF, Uhl GR, Wang JB (1996) Differential \u03bc opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J Biol Chem 271:11449\u201311454","journal-title":"J Biol Chem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-007-0201-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-007-0201-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-007-0201-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T21:14:13Z","timestamp":1737494053000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-007-0201-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,25]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,11,22]]}},"alternative-id":["201"],"URL":"https:\/\/doi.org\/10.1007\/s00210-007-0201-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2007,10,25]]}}}